Open Orphan
Business Services · Ireland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Dublin, Dublin City, IrelandPhone Number
+353 16440007Website
www.openorphan.comRevenue
$49.1 MillionIndustry
About Open Orphan
Is Open Orphan your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Open Orphan has new funding data
Website visits: Recent activity has been detected on your website
Check out if Open Orphan is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Open Orphan launches new products
Earning: See what the market has to say on Open Orphan recently announced quarterly report
Click to see if Open Orphan had a recent Job posting/layoffs
Check if Open Orphan has recently received funding, and reach out quickly before it becomes old news!
Open Orphan, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Open Orphan
Recommended Actions
Find VP level buyers at Open Orphan
Find 3 more new buyers
Company Profile Activity
Activity Insights
Open Orphan is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Open Orphan is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Open Orphan.
Open Orphan Tech Stack
A closer look at the technologies used by Open Orphan
Most Recent Scoops
Open Orphan News & Media
Is Open Orphan Plc (LON:ORPH) Trading At A 43% Discount?
How far off is Open Orphan Plc ( LON:ORPH ) from its intrinsic value? Using the most recent financial data, we'll take...Open Orphan Plc (LON:ORPH) Has Found A Path To Profitability
We feel now is a pretty good time to analyse Open Orphan Plc's ( LON:ORPH ) business as it appears the company may be...Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344
BOTHELL, Wash., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has engaged hVIVO, a subsidiary of London-based Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organization (CRO), to conduct a Phase 2a clinical trial with the Company’s novel, broad-spectrum, orally administered antiviral candidate CC-42344. This candidate represents a new class of investigational medicine designed to directly inhibitProactive news headlines including Falcon Gold, Todos Medical, Global Energy Metals, Golden Shield Resources, Kenorland Minerals and Open Orphan
New York , June 01, 2022 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Open Orphan
hVIVO is a leading contract research organization (CRO) specializing in early-phase clinical trials, particularly human challenge trials for infectious and respiratory diseases. The company offers comprehensive services from preclinical consultancy to Phase III clinical trials, supported by advanced laboratory capabilities and a robust recruitment... Read More